We also determined that the cancer-specific dye uptake and retention could be antagonized by the competitive OATP inhibitor bromosulfophthalein [11], in agreement with recent evidence indicating that OATP1B3 dominantly controls the transport of heptamethine carbocyanine dyes into cancer cells [14]. The gene discussed is SLCO1A2; the disease is cancer.